Video presentations: Personalized Medicine: are we ready?

Get Windows Media Player Download Windows Media Player for Windows or Mac

Panelist biographies and presentations

Click on the "View" link to open the video in Windows Media Player.

Steve Scherer, (Chair) Director, Centre for Applied Genomics, The Hospital for Sick Children, Canadian Institute for Advanced Research, and University of Toronto

Steve Scherer is a molecular geneticist and Member of CIFAR's Genetic Networks program. He continually receives international acclaim for his discoveries of the structure of the human genome and genetic links to disease, including autism. At the Hospital for Sick Children, Dr. Scherer is a senior scientist in Genetics and Genomic Biology, the Director of The Centre for Applied Genomics and the Associate Chief of Research. View introduction »»

Joanna Mountain, Senior Director, Research, 23andMe

Joanna Mountain is a Senior Director of Research at 23andMe. Dr. Mountain received her Ph.D. degree in Genetics from Stanford University. Dr. Mountain has published scientific papers ranging from development of algorithms for discovering geographic ancestry to the nature of the relationship between genetic diversity and categories of race and ethnicity. View presentation »»

Michael Nierenberg, Medical Director, Navigenics, Inc.

Michael Nierenberg has been the personal physician to many of Silicon Valley's CEOs, venture capitalists and lawyers, as well as prominent national and international figures. Dr. Nierenberg practiced internal medicine in Palo Alto and Menlo Park, California, for 30 years, serves as an emeritus clinical professor of medicine at Stanford University and consults in the legal and venture capital arena. View presentation »»

Harry Ostrer, Professor of Pediatrics, Pathology and Medicine, New York University Langone Medical Center

Harry Ostrer is Associate Professor of Pediatrics and Pathology and Director of the Human Genetics Program at New York University Medical Center. His current research is concentrated in the areas of genetic control of male sexual development, the genetic basis of cancer susceptibility, human population genetics, and assuring fairness in the use of genetic information. View presentation »»

Tim Caulfield, Director, Health Law Institute, University of Alberta

Timothy Caulfield is the Research Director of the Health Law Institute at the University of Alberta and a Canada Research Chair in Health Law and Policy. He is also a Professor in the Faculty of Law and the School of Public Health. His research has focussed on two general areas: biotechnology, ethics and the law; and the legal implications of health care reform in Canada. View presentation »»

David Cox, Senior Vice President and CSO, Biotherapeutics and Innovation Center, Pfizer Inc.

David Cox recently joined Pfizer as the Chief Scientific Officer of the Target Generation Unit. Prior to joining Pfizer, Dr. Cox was Professor of Genetics and Pediatrics at the Stanford University School of Medicine as well as the Co-Director of the Stanford Genome Center. He played a pivotal role in the Human Genome Project, while conducting research involving the molecular basis of human genetic disease. View presentation »»

Peter Ray, Head, Molecular Genetics, The Hospital for Sick Children, and University of Toronto

Peter Ray's work on Duchenne muscular dystrophy (DMD) resulted in the discovery of the gene responsible for this genetic disorder. He then established a diagnostic laboratory at The Hospital for Sick Children to provide carrier testing and prenatal diagnosis for families with DMD and cystic fibrosis. The laboratory has developed several of the molecular tests that are used by diagnostic laboratories in North America. View presentation »»

Cheryl Shuman, Director, Genetic Counselling, The Hospital for Sick Children, and University of Toronto

Cheryl Shuman has been a Genetic Counsellor in the Division of Clinical and Metabolic Genetics at Sick Kids since 1981. She has played a leading role in the establishment and growth of this relatively new profession in Canada. She also holds a Project Director appointment in the Research Institute based on her involvement in clinical research, genotype/phenotype correlations in overgrowth syndromes. View presentation »»